https://www.selleckchem.com/pr....oducts/pi3k-hdac-inh
b could reduce the incidence of arterial thrombosis, but a disease-modifying effect could not be demonstrated for ruxolitinib in this patient population. The objective of this study was to investigate the feasibility and efficacy of image-guided moderately hypofractionated thoracic radiotherapy (hypo-IGRT) in patients with non-small cell lung cancer (NSCLC) with poor performance status and severely limited pulmonary function and reserve. Consecutive inoperable patients who had node-positive, stage IIB-IIIC (TNM, 8th editio
Curtir
Comentario
Compartilhar
